European Medicines Agency - Regulatory - Regulation of medicines

6 -Public Involvement



    Description

Name

 

ECFS-CTN - European Cystic Fibrosis Society - Clinical Trials Network

Involvement of patients, parents or their organisations in the protocol design Yes All protocols are reviewed by a review committee including 2 patient / family reviewers. Protocol acceptance for the network sites is voted in executive committee that includes 1 patient organizaton representative.
Involvement of patients, parents or their organisations in creating the protocol info package Yes Study specific protocol information package is designed by pharma company. General information packages on clinical trials have been developed with input from patient organizatons (brochure on clinical trials, childrens leaflet on clinical trials, posters "where does my current medication come from" See https://www.ecfs.eu/ctn/patient-brochures https://www.ecfs.eu/ctn/brochure-children https://www.ecfs.eu/ctn/my-current-medication
Involvement of patients, parents or their organisations in prioritisation of needs for Clinical Trials Yes Patients and a patient organization representative are involved in protocol review including assessment of strategic fit/ priority scoring. Sites and patients regularly participate in priority setting exercises, e.g. the recent James Lind alliance priority setting exercise.